Krause und Pachernegg
Verlag für Medizin und Wirtschaft
Artikel   Bilder   Volltext

Mobile Version
A-  |   A  |   A+
Werbung
 
Grunert S, Ebel D, Schlack W, Thämer V
Intracoronary and Intravenous Magnesium Does Not Reduce Myocardial Infarct Size in a Canine Model of Regional Ischaemia and Reperfusion
Journal of Clinical and Basic Cardiology 2002; 5 (1): 23-28

PDF    Summary    Overview   

Fig. 1: Magnesium - intrakoronar - intravenös This Image - Fig. 2: Magnesium - Kalium - Serumkonzentration Fig. 3: Magnesium - Linksventrikulärer Druck Fig. 4: Magnesium-Kalium-Aspartat - Herzfrequenz Fig. 5A-B: Magnesium - Linksventrikulärer Druck Fig. 6: Magnesium - Infarktgröße
Figure/Graphic 2: Magnesium - Kalium - Serumkonzentration
Total serum concentration of magnesium and potassium during intravenous infusion of magnesium potassium aspartate or placebo. Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of reperfusion of the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or placebo was infused intravenously; values are means +/- SD
 
Magnesium - Kalium - Serumkonzentration
Previous Image Next Image   


Figure/Graphic 2: Magnesium - Kalium - Serumkonzentration
Total serum concentration of magnesium and potassium during intravenous infusion of magnesium potassium aspartate or placebo. Occl. = time period of left anterior descending artery occlusion; Reperfusion = time period of reperfusion of the left anterior descending artery; Infusion i.v. = time period when magnesium potassium aspartate or placebo was infused intravenously; values are means +/- SD
 
copyright © 2000–2025 Krause & Pachernegg GmbH | Sitemap | Datenschutz | Impressum
 
Werbung